AVALO THERAPEUTICS, INC. Investing Cash Flow
AVALO THERAPEUTICS, INC. (AVTX) reported Investing Cash Flow of -$304.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$329.93M.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $25.50M.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $2.40M.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$13.26M.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$81.72M, a 23055.06% decline from fiscal 2024.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $356.00K.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$133.00K.
- AVALO THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$95.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$329.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$304.42M 10-Q · filed 2026-08-06 | -$302.02M derived: sum of 3 quarters · filed 2026-08-06 | -$315.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $25.50M 10-Q · filed 2026-05-13 | $27.91M derived: sum of 2 quarters · filed 2026-05-13 | $14.64M derived: sum of 3 quarters · filed 2026-05-13 | -$56.22M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$10.86M derived: sum of 2 quarters · filed 2026-03-23 | -$81.72M derived: sum of 3 quarters · filed 2026-08-06 | -$81.72M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$13.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$84.12M derived: sum of 2 quarters · filed 2026-08-06 | -$84.12M 10-Q · filed 2025-11-06 | -$84.12M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$70.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$70.86M 10-Q · filed 2026-08-06 | -$70.86M derived: sum of 3 quarters · filed 2026-08-06 | -$70.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $356.00K 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $356.00K 10-Q · filed 2025-11-06 | $356.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $356.00K 10-Q · filed 2025-08-07 | $356.00K derived: sum of 3 quarters · filed 2025-08-07 | $356.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $356.00K 10-Q · filed 2025-05-12 | $356.00K derived: sum of 2 quarters · filed 2025-05-12 | $356.00K derived: sum of 3 quarters · filed 2025-05-12 | $356.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | -$133.00K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | -$133.00K 10-Q · filed 2024-11-07 | -$133.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-12 | -$133.00K 10-Q · filed 2024-08-12 | -$133.00K derived: sum of 3 quarters · filed 2024-08-12 | -$172.00K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$133.00K 10-Q/A · filed 2024-07-11 | -$133.00K derived: sum of 2 quarters · filed 2024-07-11 | -$172.00K derived: sum of 3 quarters · filed 2024-07-11 | -$228.00K derived: sum of 4 quarters · filed 2024-07-11 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$39.00K derived: sum of 2 quarters · filed 2024-03-29 | -$95.00K derived: sum of 3 quarters · filed 2024-03-29 | -$95.00K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$95.00K derived: sum of 2 quarters · filed 2023-11-09 | -$95.00K 10-Q · filed 2023-11-09 | -$106.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$56.00K 10-Q · filed 2023-08-03 | -$67.00K derived: sum of 3 quarters · filed 2023-08-03 | -$148.00K derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | -$11.00K derived: sum of 2 quarters · filed 2023-05-04 | -$92.00K derived: sum of 3 quarters · filed 2023-05-04 | -$92.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$92.00K derived: sum of 2 quarters · filed 2023-03-29 | -$92.00K derived: sum of 3 quarters · filed 2023-03-29 | -$113.00K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$81.00K derived: sum of 2 quarters · filed 2022-11-07 | -$102.00K 10-Q · filed 2022-11-07 | -$493.00K derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$21.00K 10-Q · filed 2022-08-04 | -$412.00K derived: sum of 3 quarters · filed 2022-08-04 | -$475.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$21.00K 10-Q · filed 2022-05-05 | -$412.00K derived: sum of 2 quarters · filed 2022-05-05 | -$475.00K derived: sum of 3 quarters · filed 2022-05-05 | $12.36M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$454.00K derived: sum of 2 quarters · filed 2022-03-02 | $12.38M derived: sum of 3 quarters · filed 2022-03-02 | $11.13M 10-K · filed 2022-03-02 | $11.13M 10-K · filed 2021-03-08 | |||
| 2020-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $12.77M derived: sum of 2 quarters · filed 2021-11-09 | $11.52M 10-Q · filed 2021-11-09 | $11.52M 10-Q · filed 2020-11-09 | $11.34M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | $12.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $11.59M 10-Q · filed 2021-08-02 | $11.59M 10-Q · filed 2020-08-06 | $11.41M derived: sum of 3 quarters · filed 2021-08-02 | $11.40M derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | -$1.25M 10-Q · filed 2021-05-13 | -$1.25M 10-Q · filed 2020-05-07 | -$1.43M derived: sum of 2 quarters · filed 2021-05-13 | -$1.44M derived: sum of 3 quarters · filed 2021-05-13 | -$1.53M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$180.99K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$186.08K derived: sum of 2 quarters · filed 2021-03-08 | -$277.03K derived: sum of 3 quarters · filed 2021-03-08 | -$443.00K 10-K · filed 2021-03-08 | ||||
| 2019-09-30 | -$5.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$96.04K derived: sum of 2 quarters · filed 2020-11-09 | -$262.01K 10-Q · filed 2020-11-09 | -$761.37K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$90.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$256.93K 10-Q · filed 2020-08-06 | -$756.28K derived: sum of 3 quarters · filed 2020-08-06 | $634.47K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$165.97K 10-Q · filed 2020-05-07 | -$665.33K derived: sum of 2 quarters · filed 2020-05-07 | $725.42K derived: sum of 3 quarters · filed 2020-05-07 | $718.72K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$499.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $891.39K derived: sum of 2 quarters · filed 2020-03-11 | $884.69K derived: sum of 3 quarters · filed 2020-03-11 | $865.46K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.38M derived: sum of 2 quarters · filed 2019-11-14 | $1.36M 10-Q · filed 2019-11-14 | -$17.54M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$6.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$25.93K 10-Q · filed 2019-08-08 | -$18.93M derived: sum of 3 quarters · filed 2019-08-08 | -$18.94M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$19.23K 10-Q · filed 2019-05-09 | -$18.92M derived: sum of 2 quarters · filed 2019-05-09 | -$18.93M derived: sum of 3 quarters · filed 2019-05-09 | -$18.93M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$18.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$18.91M derived: sum of 2 quarters · filed 2019-03-18 | -$18.91M derived: sum of 3 quarters · filed 2019-03-18 | -$18.91M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | -$6.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$6.19K derived: sum of 2 quarters · filed 2018-11-13 | -$7.99K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.80K 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$1.80K 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | -$34.88K 10-K · filed 2018-04-02 | |||||||
| 2015-12-31 | -$19.98K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |